Deciphering the immunological and prognostic features of hepatocellular carcinoma through ADP-ribosylation-related genes analysis and identify potential therapeutic target ARFIP2

CONCLUSIONS: The ADPRI can be used to accurately predict the prognosis and immunotherapeutic response of hepatocellular carcinoma patients and providing valuable insights for future precision treatment of patients with hepatocellular carcinoma.PMID:38302034 | DOI:10.1016/j.cellsig.2024.111073

Source: Cellular Signalling - February 1, 2024 Category: Cytology Authors: Fenfen Jiang Yan Xu Zhuang Jiang Bin Hu Qing Lv Zhiyong Wang Source Type: research